Claro Advisors LLC Abb Vie Inc. Transaction History

Claro Advisors LLC

$706 Million
Q3 2024

A detailed history of Claro Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Claro Advisors LLC holds 24,729 shares of ABBV stock, worth $4.45 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

24,729

Previous 43,339 42.94%

Holding current value

$4.45 Million

Previous $8.56 Million 42.94%

% of portfolio

0.69%

Previous 0.86%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$163.84 - $199.33 $3.05 Million - $3.71 Million	-18,610 Reduced 42.94%	24,729 $4.88 Million
Q3 2024 Oct 17, 2024	BUY	$163.84 - $199.33 $3.28 Million - $4 Million	20,043 Added 86.04%	43,339 $8.56 Million
Q2 2024 Jul 31, 2024	SELL	$154.79 - $180.76 $103,090 - $120,386	-666 Reduced 2.78%	23,296 $4 Million
Q1 2024 Apr 18, 2024	BUY	$159.82 - $182.1 $58,014 - $66,102	363 Added 1.54%	23,962 $4.36 Million
Q4 2023 Jan 22, 2024	SELL	$137.6 - $154.97 $247,955 - $279,255	-1,802 Reduced 7.09%	23,599 $3.66 Million
Q3 2023 Oct 10, 2023	BUY	$133.59 - $154.65 $211,472 - $244,810	1,583 Added 6.65%	25,401 $3.79 Million
Q2 2023 Aug 08, 2023	BUY	$132.51 - $164.9 $974,876 - $1.21 Million	7,357 Added 44.69%	23,818 $3.21 Million
Q1 2023 Apr 17, 2023	SELL	$144.61 - $166.54 $38,900 - $44,799	-269 Reduced 1.61%	16,461 $2.62 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $186,995 - $224,256	1,352 Added 8.79%	16,730 $2.71 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $501,212 - $637,204	3,642 Added 31.03%	15,378 $2.36 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $107,537 - $136,065	1,001 Added 9.32%	11,736 $1.59 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $142,150 - $161,362	1,336 Added 14.21%	10,735 $1.16 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $19,569 - $21,801	186 Added 2.02%	9,399 $1.06 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $102,709 - $113,070	1,004 Added 12.23%	9,213 $997,000
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $53,847 - $72,700	-669 Reduced 7.54%	8,209 $880,000
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $17,697 - $20,770	-206 Reduced 2.27%	8,878 $778,000
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $117,832 - $157,677	1,606 Added 21.48%	9,084 $892,000
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $262,257 - $397,614	4,066 Added 119.17%	7,478 $570,000
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $2,452 - $3,068	34 Added 1.01%	3,412 $302,000
Q3 2019 Oct 29, 2019	SELL	$62.98 - $75.72 $42,196 - $50,732	-670 Reduced 16.55%	3,378 $256,000
Q2 2019 Jul 24, 2019	SELL	$65.7 - $83.98 $17,213 - $22,002	-262 Reduced 6.08%	4,048 $294,000
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $112,392 - $132,281	1,457 Added 51.07%	4,310 $347,000
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $222,106 - $273,916	2,853 New	2,853 $270,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Claro Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claro Advisors LLC with notifications on news.

Account

Claro Advisors LLC Abb Vie Inc. Transaction History